Loading...
Guest User
Welcome! Please login.
| IPO Listing At | BSE SME |
| SME IPO Issue Type | Book Build Issue |
| Total Issue Size | ₹69.47 Cr |
| Reserved for Market Maker | ₹6.82 Cr |
| Net Issue Size | ₹69.47 Cr |
| Fresh Issue | ₹48.85 Cr |
| Offer for Sale | ₹13.80 Cr |
| Face Value | ₹10 Per Equity Share |
| Price Band | ₹135.00-142.00 per share |
| BSE Code | 544482 |
| Registrar | Kfin Technologies Ltd. |
| Lead Managers | Share India Capital Services... |
| Allotment Status |
| DRHP |
| RHP |
| Final Prospectus |
| Anchor List |
 ₹0 A/C OpeningFree MF ₹20F&O Trade ₹0Delivery 1Cr+Customers Open Free Account → |
 ₹0 A/C Opening₹0 AMC Trading Account ₹20F&O Trade ₹20Delivery FreeIPO Apply Open Free Account → |
Disclaimer: GMP is sourced from grey market dealers and is indicative only. Always conduct your own due diligence.
* Allotment, Refund, Demat Credit & Listing dates are tentative and subject to change.
Minimum bid: 2,000 shares · Multiples of 1,000 shares
Incorporated in 2004, Star Imaging and Path Lab Limited is a healthcare company providing diagnostic services across a wide range of medical tests.
The company specializes in imaging services such as X-rays, ultrasounds, CT scans, MRIs, and laboratory tests, including blood tests, urine tests, and other specialized diagnostics.
With advanced technology and experienced medical professionals, the company aims to offer accurate and timely reports to patients, helping healthcare providers in effective diagnosis and treatment.
The company has a strong presence in multiple regions, offering services to both individuals and healthcare institutions.
Services:
As of September 30th 2024, the company has 209 full time employees including executive directors.
Competitive Strengths:
The Company proposes to utilise the Net Proceeds from the Issue towards the following objects:
| # | Issue Objects | Est Amt (₹ Cr.) |
|---|---|---|
| 1 | To Meet Working Capital Requirement | 25.00 |
| 2 | Repayment/prepayment of certain borrowings availed of by the Company | 12.00 |
| 3 | Funding the Capital Expenditure towards purchase of Refurbished Medical Equipment in running facilities | 5.14 |
| 4 | General Corporate Purposes | 6.94 |
| 5 | Issue Expenses | 8.03 |
| Total | 57.11 |
| Period Ended | 31 Mar 2025 | 31 Mar 2024 | 31 Mar 2023 |
|---|---|---|---|
| Assets | 98.16 | 81.64 | 61.23 |
| Total Income | 83.79 | 79.97 | 58.68 |
| Profit After Tax | 15.96 | 12.45 | 0.58 |
| EBITDA | 28.60 | 22.34 | 5.81 |
| NET Worth | 47.15 | 31.35 | 18.93 |
| Reserves and Surplus | 33.65 | 29.85 | 17.43 |
| Total Borrowing | 32.73 | 30.64 | 26.56 |
| Amount in ₹ Crore | |||
| KPI | Mar 31, 2025 |
|---|---|
| ROE | 40.65% |
| ROCE | 29.92% |
| Debt / Equity | 0.69% |
| RoNW | 40.65% |
| PAT Margin | 19.10% |
| EBITDA Margin | 34.22% |
| Price to Book Value | 4.07 |
| Metric | Pre IPO | Post IPO |
|---|---|---|
| EPS (₹) | 11.82 | 9.16 |
| P/E (x) | 12.01 | 15.5 |
| Promoter Holding | 100% | 71.92% |
| Market Cap | ₹247.36 Cr. | |
| # | Issue Expenses | Est Amt (₹ Cr.) |
|---|---|---|
| 1 | Book Running Lead Manager | 0.47 |
| 2 | Underwriting Fees | 4.10 |
| 3 | Fees payable to Market Maker to the issue | 0.11 |
| 4 | Fees payable to the Registrar to the issue | 0.02 |
| 5 | Fees payable to the Advertising, Marketing and Publishing etc. Expenses | 0.13 |
| 6 | Fees Payable to Regulators including Stock Exchanges & Depositories | 0.23 |
| 7 | Payment for Printing & Stationery, Postage, etc. | 0.02 |
| 8 | Fees Payable to Statutory Auditor, Legal Advisors, Peer Review Auditor and other professionals | 2.96 |
Last Updated on 16-Jun-2026 18:10:14
